302 related articles for article (PubMed ID: 22042619)
1. Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4.
Backs J; Worst BC; Lehmann LH; Patrick DM; Jebessa Z; Kreusser MM; Sun Q; Chen L; Heft C; Katus HA; Olson EN
J Cell Biol; 2011 Oct; 195(3):403-15. PubMed ID: 22042619
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP represses pathological MEF2 activation by myocyte-specific hypo-phosphorylation of HDAC5.
He T; Huang J; Chen L; Han G; Stanmore D; Krebs-Haupenthal J; Avkiran M; Hagenmüller M; Backs J
J Mol Cell Cardiol; 2020 Aug; 145():88-98. PubMed ID: 32485181
[TBL] [Abstract][Full Text] [Related]
3. CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes.
Helmstadter KG; Ljubojevic-Holzer S; Wood BM; Taheri KD; Sedej S; Erickson JR; Bossuyt J; Bers DM
Basic Res Cardiol; 2021 Feb; 116(1):11. PubMed ID: 33590335
[TBL] [Abstract][Full Text] [Related]
4. Nuclear calcium/calmodulin-dependent protein kinase IIdelta preferentially transmits signals to histone deacetylase 4 in cardiac cells.
Little GH; Bai Y; Williams T; Poizat C
J Biol Chem; 2007 Mar; 282(10):7219-31. PubMed ID: 17179159
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase A-regulated assembly of a MEF2{middle dot}HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells.
Gordon JW; Pagiatakis C; Salma J; Du M; Andreucci JJ; Zhao J; Hou G; Perry RL; Dan Q; Courtman D; Bendeck MP; McDermott JC
J Biol Chem; 2009 Jul; 284(28):19027-42. PubMed ID: 19389706
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase 5 acquires calcium/calmodulin-dependent kinase II responsiveness by oligomerization with histone deacetylase 4.
Backs J; Backs T; Bezprozvannaya S; McKinsey TA; Olson EN
Mol Cell Biol; 2008 May; 28(10):3437-45. PubMed ID: 18332106
[TBL] [Abstract][Full Text] [Related]
7. MEF2 is regulated by CaMKIIδ2 and a HDAC4-HDAC5 heterodimer in vascular smooth muscle cells.
Ginnan R; Sun LY; Schwarz JJ; Singer HA
Biochem J; 2012 May; 444(1):105-14. PubMed ID: 22360269
[TBL] [Abstract][Full Text] [Related]
8. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy.
Backs J; Song K; Bezprozvannaya S; Chang S; Olson EN
J Clin Invest; 2006 Jul; 116(7):1853-64. PubMed ID: 16767219
[TBL] [Abstract][Full Text] [Related]
9. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5.
McKinsey TA; Zhang CL; Olson EN
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14400-5. PubMed ID: 11114197
[TBL] [Abstract][Full Text] [Related]
10. The δA isoform of calmodulin kinase II mediates pathological cardiac hypertrophy by interfering with the HDAC4-MEF2 signaling pathway.
Li C; Cai X; Sun H; Bai T; Zheng X; Zhou XW; Chen X; Gill DL; Li J; Tang XD
Biochem Biophys Res Commun; 2011 May; 409(1):125-30. PubMed ID: 21554860
[TBL] [Abstract][Full Text] [Related]
11. CaMKIIdelta isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses.
Zhang T; Kohlhaas M; Backs J; Mishra S; Phillips W; Dybkova N; Chang S; Ling H; Bers DM; Maier LS; Olson EN; Brown JH
J Biol Chem; 2007 Nov; 282(48):35078-87. PubMed ID: 17923476
[TBL] [Abstract][Full Text] [Related]
12. Calmodulin kinase II is required for angiotensin II-mediated vascular smooth muscle hypertrophy.
Li H; Li W; Gupta AK; Mohler PJ; Anderson ME; Grumbach IM
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H688-98. PubMed ID: 20023119
[TBL] [Abstract][Full Text] [Related]
13. Suppression of a MEF2-KLF6 survival pathway by PKA signaling promotes apoptosis in embryonic hippocampal neurons.
Salma J; McDermott JC
J Neurosci; 2012 Feb; 32(8):2790-803. PubMed ID: 22357862
[TBL] [Abstract][Full Text] [Related]
14. Calcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4.
Youn HD; Grozinger CM; Liu JO
J Biol Chem; 2000 Jul; 275(29):22563-7. PubMed ID: 10825153
[TBL] [Abstract][Full Text] [Related]
15. CaM kinase IIdeltaC phosphorylation of 14-3-3beta in vascular smooth muscle cells: activation of class II HDAC repression.
Ellis JJ; Valencia TG; Zeng H; Roberts LD; Deaton RA; Grant SR
Mol Cell Biochem; 2003 Jan; 242(1-2):153-61. PubMed ID: 12619878
[TBL] [Abstract][Full Text] [Related]
16. Activity-dependent and -independent nuclear fluxes of HDAC4 mediated by different kinases in adult skeletal muscle.
Liu Y; Randall WR; Schneider MF
J Cell Biol; 2005 Mar; 168(6):887-97. PubMed ID: 15767461
[TBL] [Abstract][Full Text] [Related]
17. The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity.
Cohen TJ; Barrientos T; Hartman ZC; Garvey SM; Cox GA; Yao TP
FASEB J; 2009 Jan; 23(1):99-106. PubMed ID: 18780762
[TBL] [Abstract][Full Text] [Related]
18. Interaction between A-kinase anchoring protein 5 and protein kinase A mediates CaMKII/HDAC signaling to inhibit cardiomyocyte hypertrophy after hypoxic reoxygenation.
Zhang X; Wang Q; Wang Z; Zhang H; Zhu F; Ma J; Wang W; Chen Z; Wang H
Cell Signal; 2023 Mar; 103():110569. PubMed ID: 36565899
[TBL] [Abstract][Full Text] [Related]
19. Opposing HDAC4 nuclear fluxes due to phosphorylation by β-adrenergic activated protein kinase A or by activity or Epac activated CaMKII in skeletal muscle fibres.
Liu Y; Schneider MF
J Physiol; 2013 Jul; 591(14):3605-23. PubMed ID: 23652597
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway.
Kozhemyakina E; Cohen T; Yao TP; Lassar AB
Mol Cell Biol; 2009 Nov; 29(21):5751-62. PubMed ID: 19704004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
